Home
Advokatfirmaet Grette DA
Advokatfirmaet Grette DA
Pricing Of Medicinal Products In Norway – An Overview
16 Jan 2013 | Norway
Advertising Of Pharmaceuticals – Recent Decisions From The Board
14 Jan 2013 | Norway
Stem Cells And Patents – Norwegian Patent Office Amends Its Guidelines
19 Nov 2012 | Norway
Automatic Substitution Of Biologicals In Norway
15 Nov 2012 | Norway
Biotech Patents In Norway: Amendment, But Little Harmonization In Sight
25 Sep 2012 | Norway
Proposed Ban On Personal Import Of Medicinal Products Ordered Via Internet
06 Sep 2012 | Norway
Increased Transparency For Applications For Marketing Authorisation
06 Aug 2012 | Norway
Biotech Patents: Norway’s Government Issues Consultation Paper On Amendments To The Patents Act
04 Jul 2012 | Norway
Pharmacovigilance Legislation Update
18 Jun 2012 | Norway
The European Ombudsman Criticises EMA For Lack Of Transparency With Regards To The Paediatric Investigation Plans
12 Jun 2012 | Norway
Advocate General Opinion In The Astrazeneca Case Of Abuse Of Dominant Position (Case C-457/10 P): Appeal From AZ Should Be Dismissed
15 May 2012 | Norway
SPCs For Medicinal Products - The Opinion Of The Advocate General In The Neurim Case
08 May 2012 | Norway
Supplementary Protection Certificates (SPC) For Combination Products. Ruling By ECJ November 24th 2011.
19 Mar 2012 | European Union
Generating authors
loading
Contact Details
Oslo
Box 1397 Vika
Oslo 0114
Norway
Telephone: 47-228-32010
Author League
Select By
Inga Kaasen
Amund Svendsen

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.